Live Chat

NHI Warns Actos Patients of Heart Failure Risks

For years, physicians have been prescribing Actos (pioglitazone) to Type 2 diabetes patients in an attempt to increase the body’s sensitivity to insulin and, as a result, control the patient’s diabetes and its effects. Recent medical studies citing the risk of bladder cancer for longer-term Actos patients, however, have caused many doctors (and a few European countries) to curtail or even prohibit the prescription of this dangerous drug.


Late last year, the National Institute of Health (NIH) warned that the dangers of Actos (pioglitazone) extended beyond the bladder. According to the NIH, pioglitazone treatments may cause or worsen congestive heart failure in patients. The NIH expressly warned potential or actual Actos patients to consult with their physician if they had experienced symptoms of heart problems, such as swelling of the extremities, heart disease, high blood pressure, and coronary artery disease.


Have you experience heart problems since beginning your Actos (pioglitazone) prescription? Fears Nachawati knows how to help you. All you have to do is give us a call! For your free consultation, call us at 1.866.545.8364 or email

Drug Litigation

NHI Warns Actos Patients of Heart Failure Risks